Gary A DeBrincat

Title: The Innovations of Gary A DeBrincat

Introduction

Gary A DeBrincat is a notable inventor based in Battle Creek, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug compositions. His work focuses on enhancing the delivery and efficacy of medications, which can greatly impact patient care.

Latest Patents

Gary A DeBrincat holds a patent for "Dual-release compositions of a cyclooxygenase-2 inhibitor." This patent involves pharmaceutical compositions that comprise one or more orally deliverable dose units. Each unit contains a selective cyclooxygenase-2 inhibitory drug of low water solubility, such as celecoxib, in both an immediate-release fraction and a controlled-release fraction. These compositions are particularly useful in the treatment or prophylaxis of conditions and disorders mediated by cyclooxygenase-2.

Career Highlights

Throughout his career, Gary has worked with Pharmacia Corporation, which is part of Pfizer, Inc. His role in this esteemed company has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His innovative approach to drug formulation has positioned him as a key figure in his field.

Collaborations

Gary has collaborated with esteemed colleagues such as Subhash Desai and Sreekant R Nadkarni. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical sciences.

Conclusion

Gary A DeBrincat's contributions to the field of pharmaceuticals through his innovative patent work exemplify the impact of dedicated inventors in improving healthcare solutions. His ongoing efforts continue to inspire advancements in drug delivery systems.